Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Disease|April 11, 2020
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patientsDamian von Eiff, Farastuk Bozorgmehr, Inn Chung, et al.
Cancer Research|July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never SmokersTimo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Cancers|May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLCSarah Richtmann, Dennis Wilkens, Arne Warth, et al.
BMC Cancer|May 10, 2011
Loss of aquaporin-4 expression and putative function in non-small cell lung cancerArne Warth, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypesRuprecht Kuner, Thomas Muley, Michael Meister, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|May 27, 2025
Impact of the number of involved lymph node zones on survival in stage IIIA-N2 lung adeno and squamous cell carcinomaRaffaella Griffo, Hans Hoffmann, Seyer Safi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2022
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offsFabian Stögbauer, Manuela Lautizi, Mark Kriegsmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lungThomas Muley, Ying He, Vinzent Rolny, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2013
Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analysesSandra Gottschling, Martin Granzow, Ruprecht Kuner, et al.
Plos One|March 30, 2016
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Svenja Ehlers-Tenenbaum, Karin Palmowski, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Disease|April 11, 2020
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patientsDamian von Eiff, Farastuk Bozorgmehr, Inn Chung, et al.
Cancer Research|July 12, 2022
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never SmokersTimo B Trefzer, Marc A Schneider, Katharina Jechow, et al.
Cancers|May 15, 2019
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLCSarah Richtmann, Dennis Wilkens, Arne Warth, et al.
BMC Cancer|May 10, 2011
Loss of aquaporin-4 expression and putative function in non-small cell lung cancerArne Warth, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2008
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypesRuprecht Kuner, Thomas Muley, Michael Meister, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|May 27, 2025
Impact of the number of involved lymph node zones on survival in stage IIIA-N2 lung adeno and squamous cell carcinomaRaffaella Griffo, Hans Hoffmann, Seyer Safi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2022
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offsFabian Stögbauer, Manuela Lautizi, Mark Kriegsmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lungThomas Muley, Ying He, Vinzent Rolny, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2013
Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analysesSandra Gottschling, Martin Granzow, Ruprecht Kuner, et al.
Plos One|March 30, 2016
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary FibrosisMichael Kreuter, Svenja Ehlers-Tenenbaum, Karin Palmowski, et al.
Pageof 23